Skip to main content

Abstract

Severe Tourette's syndrome that cannot be managed with medication is now being experimentally treated with deep brain stimulation. Ten of 11 patients in a series reported 48% reduction in motor tics and 56% reduction in phonic tics. Effects were sustained for at least 3 months, and only two patients still required pharmacotherapy. One patient discontinued the treatment because of intolerability, two patients had anxiety, and one had an electronic malfunction. The stimulating electrodes were targeted to the anteromedial globus pallidus interna. Tourette's syndrome is thought to result from a defect in the cortical-basal ganglia-thalamic-cortical neuronal circuit. Stimulation in the thalamus, pallidum, ventral caudate, and anterior internal capsule has been investigated by other centers.

Abstract

Objective:

Multiple anatomical targets for deep brain stimulation (DBS) have been proposed for the treatment of severe Tourette's syndrome. In this open study, the authors evaluated the effectiveness of DBS of the anteromedial globus pallidus interna on tic severity and common comorbidities.

Method:

Eleven patients (eight of them men, mean age=39 years) with severe and medically intractable Tourette's syndrome underwent implantation of Medtronic quadripolar electrodes in the globus pallidus interna bilaterally. The primary outcome measure was the Yale Global Tic Severity Scale. Secondary outcome measures included the Yale-Brown Obsessive Compulsive Scale, the Hamilton Depression Rating Scale, the Gilles de la Tourette Syndrome–Quality of Life Scale, and the Global Assessment of Functioning Scale. Follow-up occurred at 1 month and then at a mean of 14 months after surgery (range=4–30 months).

Results:

Ten patients (91%) reported improvement in tic severity soon after DBS. Overall, there was a 48% reduction in motor tics and a 56.5% reduction in phonic tics at final follow-up. Six patients (54.5%) had a more than 50% reduction, sustained for at least 3 months, in Yale Global Tic Severity Scale score. Only two patients required ongoing pharmacotherapy for tics after surgery, and patients improved significantly on all secondary measures. One patient did not tolerate DBS and discontinued treatment after 3 months. Greater anxiety in two patients and hardware malfunction in three patients were noteworthy adverse outcomes.

Conclusions:

The results suggest anteromedial globus pallidus interna DBS for Tourette's syndrome is an effective and well-tolerated treatment for a subgroup of patients with severe Tourette's syndrome.

Formats available

You can view the full content in the following formats:

Supplementary Material

File (appi.ajp.2012.11101583.ds001.pdf)
Supplementary tables and figures

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 860 - 866
PubMed: 22772329

History

Received: 27 October 2011
Revision received: 16 January 2012
Revision received: 21 February 2012
Accepted: 12 March 2012
Published online: 1 August 2012
Published in print: August 2012

Authors

Affiliations

Elisabeth Cannon, M.B.B.S.
From the Neuropsychiatric Institute at Prince of Wales Hospital, Randwick, New South Wales, Australia; the Centre for Clinical Research, University of Queensland, Herston, Queensland, Australia; St. Andrew's War Memorial Hospital, Spring Hill, Queensland; and the School of Psychiatry, Brain, and Ageing Research Program at the University of New South Wales, Randwick.
Peter Silburn, M.B.B.S., Ph.D.
From the Neuropsychiatric Institute at Prince of Wales Hospital, Randwick, New South Wales, Australia; the Centre for Clinical Research, University of Queensland, Herston, Queensland, Australia; St. Andrew's War Memorial Hospital, Spring Hill, Queensland; and the School of Psychiatry, Brain, and Ageing Research Program at the University of New South Wales, Randwick.
Terrence Coyne, M.B.B.S., F.R.A.C.S.
From the Neuropsychiatric Institute at Prince of Wales Hospital, Randwick, New South Wales, Australia; the Centre for Clinical Research, University of Queensland, Herston, Queensland, Australia; St. Andrew's War Memorial Hospital, Spring Hill, Queensland; and the School of Psychiatry, Brain, and Ageing Research Program at the University of New South Wales, Randwick.
Karen O'Maley, R.N., M.N.
From the Neuropsychiatric Institute at Prince of Wales Hospital, Randwick, New South Wales, Australia; the Centre for Clinical Research, University of Queensland, Herston, Queensland, Australia; St. Andrew's War Memorial Hospital, Spring Hill, Queensland; and the School of Psychiatry, Brain, and Ageing Research Program at the University of New South Wales, Randwick.
John D. Crawford, Ph.D.
From the Neuropsychiatric Institute at Prince of Wales Hospital, Randwick, New South Wales, Australia; the Centre for Clinical Research, University of Queensland, Herston, Queensland, Australia; St. Andrew's War Memorial Hospital, Spring Hill, Queensland; and the School of Psychiatry, Brain, and Ageing Research Program at the University of New South Wales, Randwick.
Perminder S. Sachdev, M.D., Ph.D.
From the Neuropsychiatric Institute at Prince of Wales Hospital, Randwick, New South Wales, Australia; the Centre for Clinical Research, University of Queensland, Herston, Queensland, Australia; St. Andrew's War Memorial Hospital, Spring Hill, Queensland; and the School of Psychiatry, Brain, and Ageing Research Program at the University of New South Wales, Randwick.

Notes

Address correspondence to Dr. Sachdev ([email protected]).

Funding Information

Dr. Silburn has received honoraria from Medtronic. Ms. O'Maley received assistance from Medtronic for attendance at CME-related activities. The other authors report no financial relationships with commercial interests.Supported by a New South Wales Institute of Psychiatry Training Fellowship and the National Health and Medical Research Council of Australia Program (P.S.S., grant 401162).

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share